Key result
THERMOCOOL SMARTTOUCH SF ablation for PAF demonstrates ~96% acute procedural effectiveness with low adverse events.
Why the study?
Does ablation with a porous-tip contact-force catheter safely and effectively achieve pulmonary vein isolation in patients with drug-refractory symptomatic paroxysmal atrial fibrillation?
Observational (n=165)
Open-label
Yes
Does ablation with a porous-tip contact-force catheter safely and effectively achieve pulmonary vein isolation in patients with drug-refractory symptomatic paroxysmal atrial fibrillation?
The use of a porous-tip contact-force catheter for paroxysmal atrial fibrillation ablation is safe and achieves high acute procedural effectiveness.
No takes yet. Share an insight, caveat, or question.
Supports porous-tip contact-force ablation safety and acute success in paroxysmal AF; leaves open need for randomized confirmation before practice change.
Chinitz et al. (2017) conducted an observational in Drug-refractory symptomatic paroxysmal atrial fibrillation (n=165). THERMOCOOL SMARTTOUCH SF Catheter was evaluated on Primary adverse events (≤1 week of index procedure). Ablation using the THERMOCOOL SMARTTOUCH SF Catheter for paroxysmal atrial fibrillation demonstrated a primary adverse event rate of 2.5% and acute procedural effectiveness of 96.2%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: